HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells.
The human HMGI-C gene encoding a member of the high mobility group protein family normally is expressed only during embryonic/fetal development but in none of the adult tissues tested so far. Recently, the HMGI-C gene has attracted a lot of interest since its rearrangements seem to underlie the development of frequent benign mesenchymal tumors. We have therefore checked CD34 positive hematopoietic stem cells and their normal and malignant descendants for HMGI-C expression. CD34 positive stem cells from healthy donors and the leukemia samples tested were positive while all peripheral blood samples from healthy volunteers were negative. We have concluded that the expression of the HMGI-C gene in leukemia seems to be a secondary effect due to abnormal stem cell proliferation and might be a sensitive tumor marker for particular types of leukemia.
Rommel
B
B
Center of Human Genetics and Genetic Counseling, University of Bremen, Germany.
Rogalla
P
P
Jox
A
A
Kalle
C V
CV
Kazmierczak
B
B
Wolf
J
J
Bullerdiek
J
J
D000208:Acute Disease; D000328:Adult; D018952:Antigens, CD34 / Q000378:metabolism; D015870:Gene Expression; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D006609:High Mobility Group Proteins / Q000096:biosynthesis*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000378:metabolism*; D007951:Leukemia, Myeloid / Q000097:blood / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D014158:Transcription, Genetic
D018952:Antigens, CD34; D006609:High Mobility Group Proteins; D009363:Neoplasm Proteins